REVELATION BIOSCIENCES, INC. Shareholders' Equity
REVELATION BIOSCIENCES, INC. (REVB) had Shareholders' Equity of $10.07 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $10.07M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $12.99M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $8.86M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $11.00M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $10.07M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $12.99M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $8.86M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $11.00M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.83M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $2.88M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $4.71M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $2.67M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.14M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $9.47M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $6.65M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $8.82M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $11.41M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $10.02M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $1.05M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $2.23M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$1.84M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | -$98.51K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | -$99.47K 10-K/A · filed 2024-09-23 | -$7.82M 10-K · filed 2022-04-15 |
| 2021-09-30 | $3.66M 10-Q · filed 2022-11-10 | -$6.60M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $6.57M 10-Q · filed 2022-11-10 | -$5.84M 10-Q · filed 2021-08-23 |
| 2021-03-31 | $8.91M 10-Q · filed 2022-11-10 | -$4.51M 10-Q · filed 2021-06-22 |
| 2020-12-31 | $3.41M 10-K · filed 2023-03-30 | $5.00M 10-K · filed 2021-03-31 |
| 2020-09-30 | $12.81K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $13.68K 10-Q · filed 2021-08-23 | |
| 2020-03-31 | $14.20K 10-Q · filed 2021-08-23 | $18.36K 10-Q · filed 2020-11-16 |
| 2019-12-31 | -$3.64K 10-Q · filed 2021-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |